Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series

Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series Neurol Ther (2018) 7:155–159 https://doi.org/10.1007/s40120-018-0092-1 CASE SERIES Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series . . . Jacobo Lester Gerardo Esteban Alvarez-Resendiz Enrique Kle ´ riga Fernando Videgaray Gerardo Zambito Received: November 4, 2017 / Published online: January 30, 2018 The Author(s) 2018. This article is an open access publication usual drugs used for hyperpyrexia, type A ABSTRACT botulinum toxin may be an effective treatment option to control both spasticity and fever. Introduction: Brain and spinal cord injuries may cause very severe spasticity that occasion- Keywords: Botulinum toxin; Fever; Spasticity ally may be associated with persistent fever. Case Series: We present 14 patients with spas- ticity and persistent fever, treated with botuli- INTRODUCTION num toxin type A. Their spasticity improved and the fever resolved within a period no The hypothalamus is the regulatory center for greater than 48 h. In all cases, infectious and body temperature in humans [1], although the other non-infectious causes were ruled out. diencephalon and spinal cord also contribute Conclusions: When sustained tonic muscular [2]. If one of these structures is damaged, tem- activity is associated with a significant increase perature elevations above 38.3 C can occur [3]. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neurology and Therapy Springer Journals

Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series

Download PDF
5 pages

Loading next page...
 
/lp/springer_journal/treatment-with-botulinum-toxin-for-refractory-fever-caused-by-severe-0LRQZ0wymt
Publisher
Springer Journals
Copyright
Copyright © 2018 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Neurology
ISSN
2193-8253
eISSN
2193-6536
DOI
10.1007/s40120-018-0092-1
Publisher site
See Article on Publisher Site

Abstract

Neurol Ther (2018) 7:155–159 https://doi.org/10.1007/s40120-018-0092-1 CASE SERIES Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series . . . Jacobo Lester Gerardo Esteban Alvarez-Resendiz Enrique Kle ´ riga Fernando Videgaray Gerardo Zambito Received: November 4, 2017 / Published online: January 30, 2018 The Author(s) 2018. This article is an open access publication usual drugs used for hyperpyrexia, type A ABSTRACT botulinum toxin may be an effective treatment option to control both spasticity and fever. Introduction: Brain and spinal cord injuries may cause very severe spasticity that occasion- Keywords: Botulinum toxin; Fever; Spasticity ally may be associated with persistent fever. Case Series: We present 14 patients with spas- ticity and persistent fever, treated with botuli- INTRODUCTION num toxin type A. Their spasticity improved and the fever resolved within a period no The hypothalamus is the regulatory center for greater than 48 h. In all cases, infectious and body temperature in humans [1], although the other non-infectious causes were ruled out. diencephalon and spinal cord also contribute Conclusions: When sustained tonic muscular [2]. If one of these structures is damaged, tem- activity is associated with a significant increase perature elevations above 38.3 C can occur [3].

Journal

Neurology and Therapy – Springer Journals

Published: Jan 30, 2018

References

  • Hyperpyrexia associated with sustained muscle contractions: an alternative diagnosis to central fever
    Sneed, RC
  • Hyperthermia associated with baclofen withdrawal and increased spasticity
    Mandac, BR; Hurvitz, EA; Nelson, VS
  • Fever of unexplained origin: report on 100 cases
    Petersdorf, RG; Beeson, PB
  • Circulating catecholamines and sympathetic activity after head injury
    Clifton, GL; Ziegler, MG; Grossman, RG
  • Paroxysmal sympathetic hyperactivity after severe brain injury
    Lump, D; Moyer, M
  • Early temperature and mortality in critically ill patients with acute neurological diseases: trauma and stroke differ from infection
    Saxena, M; Young, P; Pilcher, D
  • Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis
    Greer, DM; Funk, SE; Reaven, NL; Ouzounelli, M; Uman, GC
  • Neuroleptic malignant syndrome and malignant hyperthermia. Important issues for the medical consultant
    Heiman-Patterson, TD
  • The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture
    Lance, JW
  • Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-interdisciplinary working group for movement disorders task force
    Dressler, D; Bhidayasiri, R; Bohlega, S; Chahidi, A; Chung, TM; Ebke, M
  • Clinical applications of botulinum toxin
    Dressler, D
  • Malignant hyperthermia
    MacLennan, DH; Phillips, MS
  • Hypothesis: exertional heat stroke-induced myopathy and genetically inherited malignant hyperthermia represent the same disorder, the human stress syndrome
    Zhao, X; Song, Q; Gao, Y
  • Fever and rigidity
    Howard, ZD; Rempell, JS; Nadel, ES; Brown, DFM
  • Interrater reliability of a modified ashworth scale of muscle spasticity
    Bohannon, RW; Smith, MB
  • Baclofen in the therapeutic of sequele of traumatic brain injury: spasticity
    Pérez-Arredondo, A; Cázares-Ramírez, E; Carrillo-Mora, P; Martínez-Vargas, M; Cárdenas-Rodríguez, N; Coballase-Urrutia, E
  • Anaesthetic deaths in a family
    Denborough, MA; Forster, JFA; Lovell, RR; Maplestone, PA; Villiers, JD
  • Stress-induced malignant hyperthermia in a head-injured patient. Case report
    Feuerman, T; Gade, GF; Reynolds, R
  • Fatal malignant hyperpyrexia in a cervical spine- injured patient
    Steele, SR; Martin, MJ; Mullenix, PS; Long, WB; Gubler, KD
  • Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis
    Wappler, F; Fiege, M; Steinfath, M; Agarwal, K; Scholz, J; Singh, S
  • Ca2+ signalling and muscle disease
    MacLennan, DH
  • Paroxysmal autonomic instability with dystonia after brain injury
    Blackman, JA; Patrick, PD; Buck, ML; Rust, RS
  • Malignant hyperthermia. Dantrolene-dynamics and kinetics
    Harrison, GG
  • Botulism
    Wenham, T; Cohen, A
  • Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals
    Paiva, A; Meunier, FA; Molgó, J; Aoki, KR; Dolly, JO